UBS Call 38 RWE 17.06.2024/ DE000UK9Y913 /
6/10/2024 8:27:27 AM | Chg.-0.007 | Bid11:25:19 AM | Ask11:25:19 AM | Underlying | Strike price | Expiration date | Option type |
---|---|---|---|---|---|---|---|
0.072EUR | -8.86% | 0.077 Bid Size: 10,000 |
- Ask Size: - |
RWE AG INH O.N. | 38.00 EUR | 6/17/2024 | Call |
GlobeNewswire
6/5
Intuitive Announces FDA Clearance of Revised da Vinci Xi and X Labeling on Radical Prostatectomy
GlobeNewswire
6/4
Annexon Announces Positive Topline Results from Pivotal Phase 3 Trial for First-in-Class C1q Blockin...
GlobeNewswire
5/23
RWE signs two 15-year Power Purchase Agreements with Microsoft to supply clean energy from two onsho...
GlobeNewswire
5/20
RWE expands U.S. development portfolio with new project acquisitions across three states
GlobeNewswire
5/13
Annexon Reports First Quarter 2024 Financial Results and Key Anticipated Milestones
GlobeNewswire
5/2
Using clinical-led AI, Truveta expands clinical notes and medical images available to advance resear...
GlobeNewswire
4/25
Truveta delivers largest and most complete mother and child EHR dataset to advance healthcare
GlobeNewswire
3/26
Annexon Reports Fourth Quarter and Year-End 2023 Financial Results and Key Anticipated Milestones
GlobeNewswire
10/23/2023
More than 50 organizations choose Truveta for the most complete, timely, and clean EHR data to study...